120 related articles for article (PubMed ID: 36804046)
21. Financial IncEntives for Smoking TreAtment: protocol of the FIESTA trial and FIESTA Oral Microbiome Substudy.
French KM; Gonzalez SZ; Sherman SE; Link AR; Malik SZ; Tseng CH; Jumkhawala SA; Tejada B; White A; Ladapo JA
Trials; 2018 Nov; 19(1):646. PubMed ID: 30463608
[TBL] [Abstract][Full Text] [Related]
22. Comparative Effectiveness of Group-Delivered Acceptance and Commitment Therapy versus Cognitive Behavioral Therapy for Smoking Cessation: A Randomized Controlled Trial.
McClure JB; Bricker J; Mull K; Heffner JL
Nicotine Tob Res; 2020 Mar; 22(3):354-362. PubMed ID: 30590810
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of an individual acceptance and commitment therapy for smoking cessation, delivered face-to-face and by telephone to adults recruited in primary health care settings: a randomized controlled trial.
Mak YW; Leung DYP; Loke AY
BMC Public Health; 2020 Nov; 20(1):1719. PubMed ID: 33198700
[TBL] [Abstract][Full Text] [Related]
24. The acceptance and commitment therapy for smoking cessation in the primary health care setting: a study protocol.
Mak YW; Loke AY
BMC Public Health; 2015 Feb; 15():105. PubMed ID: 25879419
[TBL] [Abstract][Full Text] [Related]
25. Effect of a mobile phone intervention on quitting smoking in a young adult population of smokers: randomized controlled trial study protocol.
Baskerville NB; Struik LL; Hammond D; Guindon GE; Norman CD; Whittaker R; Burns CM; Grindrod KA; Brown KS
JMIR Res Protoc; 2015 Jan; 4(1):e10. PubMed ID: 25599695
[TBL] [Abstract][Full Text] [Related]
26. Brief Advice, Nicotine Replacement Therapy Sampling, and Active Referral for Expectant Fathers Who Smoke Cigarettes: A Randomized Clinical Trial.
Luk TT; Lam TH; Leung WC; Leung KY; Cheung KW; Kwa C; Siong KH; Tang KK; Lee KW; Hsieh CJ; Wu YS; Li WH; Wang MP
JAMA Intern Med; 2021 Aug; 181(8):1081-1089. PubMed ID: 34125135
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of Mobile Phone-Delivered Smoking Cessation Interventions for Socioeconomically Disadvantaged Individuals: A Randomized Clinical Trial.
Vidrine DJ; Frank-Pearce SG; Vidrine JI; Tahay PD; Marani SK; Chen S; Yuan Y; Cantor SB; Prokhorov AV
JAMA Intern Med; 2019 Feb; 179(2):167-174. PubMed ID: 30556832
[TBL] [Abstract][Full Text] [Related]
28. A randomized controlled trial to assess the efficacy of an interactive mobile messaging intervention for underserved smokers: Project ACTION.
Vidrine DJ; Fletcher FE; Danysh HE; Marani S; Vidrine JI; Cantor SB; Prokhorov AV
BMC Public Health; 2012 Aug; 12():696. PubMed ID: 22920991
[TBL] [Abstract][Full Text] [Related]
29. Rationale, design, and protocol for a hybrid type 1 effectiveness-implementation trial of a proactive smoking cessation electronic visit for scalable delivery via primary care: the E-STOP trial.
Fahey MC; Wahlquist AE; Diaz VA; Player MS; Natale N; Sterba KR; Chen BK; Hermes EDA; Carpenter MJ; Dahne J
BMC Prim Care; 2023 Nov; 24(1):254. PubMed ID: 38030991
[TBL] [Abstract][Full Text] [Related]
30. Smoking Cessation Smartphone App Use Over Time: Predicting 12-Month Cessation Outcomes in a 2-Arm Randomized Trial.
Bricker JB; Mull KE; Santiago-Torres M; Miao Z; Perski O; Di C
J Med Internet Res; 2022 Aug; 24(8):e39208. PubMed ID: 35831180
[TBL] [Abstract][Full Text] [Related]
31. Interventions to reduce tobacco use in people experiencing homelessness.
Vijayaraghavan M; Elser H; Frazer K; Lindson N; Apollonio D
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013413. PubMed ID: 33284989
[TBL] [Abstract][Full Text] [Related]
32. Comparative effectiveness of adding weight control simultaneously or sequentially to smoking cessation quitlines: study protocol of a randomized controlled trial.
Bush T; Lovejoy J; Javitz H; Magnusson B; Torres AJ; Mahuna S; Benedict C; Wassum K; Spring B
BMC Public Health; 2016 Jul; 16():615. PubMed ID: 27443485
[TBL] [Abstract][Full Text] [Related]
33. Patient navigation and financial incentives to promote smoking cessation in an underserved primary care population: A randomized controlled trial protocol.
Quintiliani LM; Russinova ZL; Bloch PP; Truong V; Xuan Z; Pbert L; Lasser KE
Contemp Clin Trials; 2015 Nov; 45(Pt B):449-457. PubMed ID: 26362691
[TBL] [Abstract][Full Text] [Related]
34. A Mobile Health Solution Complementing Psychopharmacology-Supported Smoking Cessation: Randomized Controlled Trial.
Carrasco-Hernandez L; Jódar-Sánchez F; Núñez-Benjumea F; Moreno Conde J; Mesa González M; Civit-Balcells A; Hors-Fraile S; Parra-Calderón CL; Bamidis PD; Ortega-Ruiz F
JMIR Mhealth Uhealth; 2020 Apr; 8(4):e17530. PubMed ID: 32338624
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of a chat-bot for the adult population to quit smoking: protocol of a pragmatic clinical trial in primary care (Dejal@).
Avila-Tomas JF; Olano-Espinosa E; Minué-Lorenzo C; Martinez-Suberbiola FJ; Matilla-Pardo B; Serrano-Serrano ME; Escortell-Mayor E;
BMC Med Inform Decis Mak; 2019 Dec; 19(1):249. PubMed ID: 31796061
[TBL] [Abstract][Full Text] [Related]
36. Effects of a culturally specific tobacco cessation intervention among African American Quitline enrollees: a randomized controlled trial.
Webb Hooper M; Carpenter K; Payne M; Resnicow K
BMC Public Health; 2018 Jan; 18(1):123. PubMed ID: 29321008
[TBL] [Abstract][Full Text] [Related]
37. Can a smartphone application help Hispanic/Latinx adults quit smoking? A randomized trial secondary analysis.
Santiago-Torres M; Mull KE; Sullivan BM; Zvolensky MJ; Bricker JB
J Contextual Behav Sci; 2022 Oct; 26():261-270. PubMed ID: 36437818
[TBL] [Abstract][Full Text] [Related]
38. Study protocol for a hybrid type 1 effectiveness-implementation trial testing virtual tobacco treatment in oncology practices [Smokefree Support Study 2.0].
Goshe BM; Rasmussen AW; Wagner LI; Sicks JD; Gareen IF; Carlos RC; Herman BA; Walter AW; Regan S; Levy DE; Mahon I; Muzikansky A; Neil JM; Lui M; Dilip D; Malloy L; Gonzalez I; Finkelstein-Fox L; McCann C; Perez E; Ostroff JS; Park ER
BMC Public Health; 2022 Jul; 22(1):1359. PubMed ID: 35841024
[TBL] [Abstract][Full Text] [Related]
39. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
